HOXA9 and acute myeloid leukemia: In acute myeloid leukemia (AML), NAT10 knockout blocks the translational efficiency of target genes such as SLC1 A4 and HOXA9/MENIN, disrupts serine metabolic reprogramming, impairs leukemia stem cell self-renewal, and enhances chemotherapeutic sensitivity [176].